Ocular Therapeutix™ to Present at the Piper Jaffray 27th Annual Healthcare Conference
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President, Chief Executive Officer and Chairman, will participate in a fireside chat presentation at the Piper Jaffray 27th Annual Healthcare Conference on Wednesday, December 2, 2015 at 9:30 a.m. ET at The New York Palace Hotel in New York C
